Your session is about to expire
← Back to Search
Abaloparatide for Spinal Fusion
Study Summary
This trial is studying whether a medication can improve surgical outcomes, pain, and bone mass in postmenopausal women who need lumbar spinal fusion surgery.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have high calcium levels or an active parathyroid disorder.My cancer has spread to other parts of my body or I have multiple myeloma.I have had kidney stones multiple times or within the last 2 years.I am willing to take either a placebo or abaloparatide.I have used Forteo or Tymlos for more than a year or within the last 6 months.I need spine surgery for a lower back condition.I have Paget's disease or have had radiation therapy, increasing my risk of bone cancer.I have been taking oral steroids daily for over a month for an inflammatory condition.I am able to understand and sign the informed consent.I have been treated with bisphosphonates for over a year in the last 5 years.I have not had a menstrual cycle for over 12 months.I am 50 years old or older.I am having surgery to correct a previous lower back fusion surgery.
- Group 1: Abaloparatide
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What other research has there been on Abaloparatide?
"At the moment, there are 7 research studies being conducted on Abaloparatide with 0 of them in Phase 3. Although most trials for Abaloparatide take place in Madison, Wisconsin, 11 different locations are running these tests."
Has the US Food and Drug Administration cleared Abaloparatide for use?
"Abaloparatide's safety is rated at a 2 because, while there is some evidence backing its safety, none of the clinical data collected thus far supports efficacy."
Are new participants still being welcomed into this research project?
"The study, which is currently recruiting patients, was initially posted on 8/14/2019. The listing was last updated on 3/29/2022 according to data from clinicaltrials.gov"
How many human test subjects are a part of this clinical trial?
"That is correct, the online information indicates that this trial is still actively looking for subjects. The listing appeared on 8/14/2019 and was edited as recently as 3/29/2022. Currently, 72 individuals are needed to enroll at a single site."
Share this study with friends
Copy Link
Messenger